Sign in
Taking people in ItalyNo phase

Brain stimulation for balance and coordination problems in cerebellar multiple system atrophy

Tests gentle electrical brain stimulation against fake stimulation in people with cerebellar multiple system atrophy.

Key facts

Who runs it
University of Salerno
Where
Salerno, ItalySee the site
Trial code
Registry title
Efficacy and Safety of Transcranial dIrect Current stiMulation in Multiple System Atrophy-Cerebellar Variant
Status
Recruiting
People taking part
30 people, planned
Started
3 Jul 2023
Expected to end
Dec 2027
Type of study
Interventional, 2 groupsOne group gets a sham (pretend) treatment, for comparison.
Treatments tested
  • Anodal transcranial direct current stimulation (a-tDCS)
  • Sham stimulation
Record updated
29 April 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults with the cerebellar type of multiple system atrophy (MSA-C) who can still walk. It tests a mild electrical brain stimulation (tDCS) against a fake (sham) stimulation.

Age
40 Years to 90 Years
Sex
All sexes can join.
Disease stage
Multiple system atrophy, cerebellar type, by the Movement Disorder Society criteria (Wenning et al 2022). People must be able to walk alone or with minimum support.
Earlier treatment
People who had brain or nerve surgery before cannot join.

Main reasons for not taking part

  • Electrical devices in the body, such as a pacemaker or Deep Brain Stimulation (DBS)
  • Trouble understanding Italian, or severe sight or hearing problems
  • Past drug abuse or severe psychiatric disorders
  • Past mini-strokes (transient ischemic attacks), blood vessel damage in the brain, seizures or severe heart problems
  • Pregnancy

The registry criteria, word for word

Show all 11 criteriaShow less

Who can take part

  • Multiple system atrophy cerebellar variant according with the Movemente Disorder Society criteria (Wenning et al 2022)
  • Ability to walk either indipendently or with a minimum support

Who cannot take part

  • Seizures or severe heart problems and previous neurosurgical operations
  • History of drug abuse
  • History of severe psychiatric disorders
  • History of transient ischemic attacks
  • Presence of electrical stimulators (for example, pacemaker, Deep Brain Stimulation, DBS)
  • Difficult in understanding Italian language
  • Presence of severe sensory deficits (for example, visual or hearing impairments)
  • Cortical or sub-cortical vascular lesions
  • Pregnancy

Check if you might fit

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 40 and 90 years old?

Where in Italy

  • Centro per le Malattie Neurodegenerative (CEMAND) Dipartimento di Medicina e chirurgia, Sezione Neuroscienze, Università di SalernoSalerno, ItalyContact: Roberto Erro MD, PhDTaking people

About the trial

What the trial wants to find out

This is a double-blind, randomized, sham-controlled clinical trial that aim to verify the safety and the efficacy of anodal transcranial direct current stimulation (tDCS) cerebellar symptoms in Multiple System Atrophy type C (MSA).

The 2 groups in the trial

  • Real tDCS groupTreatment being tested

    Partecipants receive anodal tDCS over the cerebellum area (2 cm under the inion, using a 7 × 5 cm sponge electrode), with the cathode being applied either to the right deltoid muscle (arm 1: cerebellar stimulation) or over the spinal lumbar enlargement (2 cm under T11; arm 2: cerebellar-spinal stimulation) using a sponge electrode of the same size as the anode for 5 days/week for 2 weeks

    Treatment: Anodal transcranial direct current stimulation (a-tDCS)

  • Sham groupSham treatment, for comparison

    Partecipants receive sham stimulation over the cerebellum area (2 cm under the inion, using a 7 × 5 cm sponge electrode), with the cathode being applied either to the right deltoid muscle (arm 1: cerebellar stimulation) or over the spinal lumbar enlargement (2 cm under T11; arm 2: cerebellar-spinal stimulation) using a sponge electrode of the same size as the anode for 5 days/week for 2 weeks

    Treatment: Sham stimulation

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
Efficacy and Safety of Transcranial dIrect Current stiMulation (tDCS) on Cerebellar Symptoms in Multiple System Atrophy-Cerebellar Variant (MSA-C) (STIM-MSA)
Plain-language title
Brain stimulation for balance and coordination problems in cerebellar multiple system atrophyGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 14 November 2026.
Fit questions
Built from NCT06821256, who can take part
Record updated
29 April 2026